# Infectious Disease Agents: Antivirals â€“ HIV\*

**LENGTH OF AUTHORIZATIONS:**  365 Days

**GRANDFATHERING:**

Patients who have a claim for a non-preferred drug in the previous 120 days will be automatically approved to continue the drug through the automated PA system. Patients who have taken the drug in the previous 120 days, but do not have claims history (e.g. new to Medicaid), will be approved for PA after prescriber contact.

**PRIOR AUTHORIZATION CRITERIA:**

Is there any reason the patient cannot be changed to a medication not requiring prior approval?

Acceptable reasons include:

1.  Allergy to medications not requiring prior approval
2.  Contraindication to recommended regimens not requiring prior approval
3.  History of unacceptable/toxic side effects to medications not requiring prior approval
4.  Has the patient had a therapeutic trial of at least 30 days with at least one medication not requiring prior approval? If applicable, the request must address the inability to use the individual components.

**ADDITIONAL CRITERIA FOR RUKOBIA ER**

1\. Patient has been diagnosed with multidrug-resistant HIV-1 infection

Symtuza request must document clinical justification for patient inability to use the individual components (Prezcobix and Descovy)

AR - Isentress chewable tablet: a PA is required for patients over 11 years old
